Clinical Trial Update: Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 PK study evaluating the effect of erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CHF6001
• ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED